No Data
Earnings Preview: Durect to Report Financial Results Post-market on March 26
Express News | DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Durect Corporation Announces Board Member's Retirement
H.C. Wainwright Views Durect as Significant 'Going Concern' Risk
151323992 : This one looks promising